Kura Oncology, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC KURA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

106,889

Value ($000)

1,111

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,111	0.0%	106,889	12/31/2025
2025 Q3	11/14/2025	980	0.0%	110,766	9/30/2025
2025 Q2	8/14/2025	1,095	0.0%	189,720	6/30/2025
2025 Q1	5/19/2025	1,004	0.0%	152,132	3/31/2025
2024 Q4	2/14/2025	1,147	0.0%	131,718	12/31/2024
2024 Q3	11/14/2024	2,397	0.0%	122,668	9/30/2024
2024 Q2	8/14/2024	2,576	0.0%	125,104	6/30/2024
2024 Q1	5/15/2024	1,849	0.0%	86,666	3/31/2024
2023 Q4	2/14/2024	1,177	0.0%	81,856	12/31/2023
2023 Q3	11/13/2023	747	0.0%	81,856	9/30/2023
2023 Q2	8/11/2023	489	0.0%	39,969	6/30/2023
2023 Q1	5/15/2023	489	0.0%	39,969	3/31/2023
2022 Q4	2/14/2023	570	0.0%	45,919	12/31/2022
2022 Q3	11/14/2022	627	0.0%	45,919	9/30/2022
2022 Q2	8/12/2022	6,241	0.0%	340,462	6/30/2022
2022 Q1	5/16/2022	5,637	0.0%	350,531	3/31/2022
2021 Q4	2/14/2022	5,205	0.0%	371,750	12/31/2021
2021 Q3	11/15/2021	7,176	0.0%	383,135	9/30/2021
2021 Q2	8/16/2021	8,187	0.0%	392,663	6/30/2021
2021 Q1	5/14/2021	8,480	0.0%	299,976	3/31/2021
2020 Q4	3/1/2021	8,469	0.0%	259,316	12/31/2020
2020 Q3	11/13/2020	1,186	0.0%	38,700	9/30/2020
2020 Q2	8/14/2020	623	0.0%	38,240	6/30/2020
2020 Q1	5/15/2020	154	0.0%	15,516	3/31/2020
2019 Q4	2/14/2020	327	0.0%	23,793	12/31/2019